Peer Review History
| Original SubmissionJuly 17, 2024 |
|---|
|
PONE-D-24-27113Phenotypes of painful TMD in discordant monozygotic twins according to a cognitive-behavioral-emotional model: a case-control studyPLOS ONE Dear Dr. Leite-Panissi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please insert comments here and delete this placeholder text when finished. Dear Authors, Kindly review the manuscript ad make necessary changes as suggested by the reviewers. Kindly submit the revised version. Best Wishes ============================== Please submit your revised manuscript by Oct 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Kumar Chandan Srivastava, BDS, MDS, PhD, MFD RSCI, MFDS RCPS, MFDS RCSEd MDT Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. We note that your Data Availability Statement is currently as follows: "We need the journal’s help to make your data available." Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition ). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories . If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. Additional Editor Comments : Dear Authors, Kindly review the manuscript ad make necessary changes as suggested by the reviewers. Kindly submit the revised version. Best Wishes [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The topic of the study is both interesting and well-defined. However, the discussion section could benefit from further refinement. In the first paragraph of the introduction, it would be beneficial to better describe the specificity of the TMD diagnoses. For instance, the study focuses specifically on painful TMD, a point that could be highlighted earlier in the introduction. The methodology is robust and well-detailed. The statistical analyses and results are presented clearly and concisely. It would be helpful to explicitly mention which variables were excluded due to collinearity during the regression model formation. While this is somewhat implied, providing this information would aid in the reader’s interpretation. The discussion section is somewhat lengthy and does not thoroughly explore the study’s findings. Previous studies could be summarized more concisely and directly linked to your results. I suggest placing greater emphasis on the aspects related to epigenetics, the specificity of your sample, and the extensive number of variables investigated to construct the model—these are significant strengths of your study. Another aspect that could be more thoroughly discussed is the idea that in genetically identical individuals, other factors may play a more significant role than those typically identified in genetically diverse populations. The conclusion could be more concise and clear. *Note:* On page 12, in Table 3, the label for G7 is missing a "T." Reviewer #2: Phenotypes of painful TMD in discordant monozygotic twins according to a cognitivebehavioral-emotional model: a case-control study It was described that the objective of this study “was to investigate variables based on a cognitive-behavioral-emotional model related to the development of painful temporomandibular disorders (TMD) in a sample of monozygotic twins discordant for the condition.” Please see my comments below: 1. Objective. It is important a clarification why sociodemographic profile, pain sensitivity (pain threshold to pressure, allodynia, and hyperalgesia), oral behaviors, pain vigilance, central sensitization, pain intensity and interference, trigeminal and extratrigeminal pain areas were considered cognitive-behavioral-emotional variables. 2. Method. It is important for the authors to describe the cohort from which the painful TMD patients were recruited, including how many declined participation and how many were excluded. Additionally, the rationale for including only patients aged 18-55 years needs clarification, as well as the reason for excluding older individuals. It is also unclear why women using interocclusal plates or undergoing other TMD therapies (such as acupuncture, laser therapy, physical therapy, or pain medication) were excluded. This suggests that the study may have selectively included patients with only mild pain. 3. Statistical analysis. The authors could use VIF to assess multicollinearity. Additionally, it is important to note that logistic regression is not a linear regression model. If odds ratios were estimated, then logistic regression was conducted, not linear analysis. I recommend that the authors specify the alpha level in the methods section and report p-values in the results section. It may also be beneficial for the authors to consult a statistician to review the analysis. 4. Results. The authors described an increased likelihood of TMD with rising scores in left-sided masseter face pain sensitivity, total pain catastrophizing, difficulty in externalizing feelings, and the distraction facet of the FFMQ scale. However, the adjusted model showed that none of these variables were significantly associated with painful TMD. 5. Conclusion. Therefore, I disagree with the authors' conclusion that the cognitive-behavioral-emotional model studied in this case-control study of monozygotic twins discordant for painful TMD suggests that facial pain sensitivity, pain catastrophizing, difficulty in externalizing feelings, and the distraction facet of mindfulness increase the likelihood of developing painful TMD. My conclusion is the opposite, as none of these factors were significantly associated with painful TMD. 6. Tables Table 1 should specify the sample size included and indicate whether the analysis is crude or multivariable. It is also important to note that none of the variables were found to be associated with painful TMD. Table 2 presents result from a multiple logistic regression analysis, not a linear regression, as indicated by the estimated odds ratios. Again, no associations were found with painful TMD. Table 3 should include the number of participants in each group. 7. English revision is needed. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: Yes: Ana Velly ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
<div>PONE-D-24-27113R1Phenotypes of painful TMD in discordant monozygotic twins according to a cognitive-behavioral-emotional model: a case-control studyPLOS ONE Dear Dr. Leite-Panissi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. After reviewing the article, important revisions were identified to enhance the clarity and consistency of the manuscript before it is ready for publication. Key points include the need for language editing, adjustments to the abstract to better clarify the objectives, methodology, and clinical relevance, as well as greater precision in the introduction and conclusion to align them with the results. In the methodology, more detailed information on the recruitment process and clear justifications for exclusions and analyses performed were requested. Additionally, inconsistencies in the statistical approach were highlighted, with a recommendation for review by a statistician to ensure the appropriateness of the model and interpretations. Please submit your revised manuscript by Jan 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Cristiano Miranda de Araujo Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: No Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: No Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: No Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: This study addresses an interesting topic; however, the manuscript requires significant revisions. Please refer to my comments below: 1. English Language: A thorough review and revision of the English language are necessary to improve clarity and readability. 2. Abstract: a. The abstract lacks clarity. The aim and methodology are not clearly articulated. For instance, it is unclear how the 20 monozygotic twins with discordant conditions were selected. b. Conclusion and Clinical Relevance are wrong. c. Presentation: The frequent use of nested parentheses is not appropriate (e.g., (OR=3.29; 95% CI=(0.17–62.8), p=0.428)). Please revise to ensure a cleaner and more professional presentation. 3. Introduction: Please note that self-reported parafunctions do not fall under the category of "orofacial symptoms, the frequency of somatic symptoms, poor sleep quality, and genetic and epigenetic factors." This distinction should be clarified in the introduction. 4. Method: a. Suggestion: Begin by clearly describing the recruitment process for the study participants. Following this, provide details about the sample: 38 monozygotic twins were initially evaluated, and among them, 12 pairs met the inclusion criteria for discordance in painful TMD. b. Age Inclusion Criterion: The authors justify including only individuals aged 18–55 to reduce potential age-related confounding factors. While this is a valid rationale, it should also be acknowledged as a limitation. Age could have been accounted for as a potential confounder in the analysis, and the analysis could have been stratified by age to address this concern more comprehensively. c. Statistical Model Explanation: Upon reviewing the explanation of the statistical model, it appears the authors may not have fully understood the initial comment, as their response does not align with the original concern. If the adjusted model includes variables that are not statistically significant, the authors must explain the implications of these findings, particularly by referencing the 95% confidence intervals as a guide. Again, I strongly suggest consulting a statistician to address these issues thoroughly. Multicollinearity: I disagree with the approach used to assess multicollinearity. Variance Inflation Factor (VIF) should be the primary method, as it evaluates the combined effect of all predictors and provides a direct measure of their impact on the regression model. Correlation analysis can be used as a complementary tool to identify pairwise relationships that may warrant further investigation or justify the use of VIF. To address potential confounding (line 16, page 7), the authors could adjust the analysis rather than relying on exclusions, which should only be employed if there are very few cases within the excluded group. Additionally, the authors should list the number of subjects excluded in each group. Statistical Analysis: This section requires verification by a statistician, as it is confusing and contains inaccuracies. For instance, the statement, "The association of each factor with TMD was investigated by fitting pairwise conditional simple logistic linear regression models," is problematic. Is the analysis "simple"? Are "logistic" and "linear" being used interchangeably? Clarify whether collinearity was assessed using logistic regression models and provide an accurate description of the statistical approach. Why was linear regression used (line 28, page 9)? The authors need to specify the dependent variable to justify the choice of this statistical method. The explanation of the four excluded variables is unclear. This section reads more like results than methodology. For example, the finding of a borderline association between trapezius pain threshold and TMD (OR = 0.29, 95% CI = 0.07–1.20, p = 0.088) raises questions—why was this variable excluded despite its potential relevance? The authors should provide a clear rationale for this decision. The sentence, “Although these variables showed associations with TMD in the bivariate analysis, their high correlation with other variables in the model necessitated their exclusion,” is unclear and problematic. Are the authors excluding variables that are associated with TMD? This contradicts the study's objective. I strongly recommend conducting a principal component analysis (PCA) to address multicollinearity and using the resulting components in the logistic regression instead of excluding potentially relevant variables. 5. Results. a. The sentence, "The participants were not recruited from any Brazilian-specific cohort," should be deleted. Before discussing the evaluation of the 38 monozygotic twins, the authors need to clearly explain the recruitment process of the participants. b. The statement, “The variables that showed a positive association (according to the OR), however, without statistical significance, were: pain duration…” is incorrect. What is the risk of a Type I error here? Focus on interpreting the 95% confidence intervals (CIs) and p-values. 6. Discussion: The sentence, “Our findings revealed that increased pain sensitivity in the masseter muscle, higher levels of pain catastrophizing, difficulty in externalizing feelings, and higher scores on the distraction facet of mindfulness were significant predictors of painful TMD. These results provide evidence that, even in genetically identical individuals, cognitive and emotional factors play a crucial role in the manifestation of chronic pain associated with TMD” (lines 6–10, page 16), is incorrect and does not align with the study's findings. This discussion must be revised to accurately reflect the results. The claims about significant predictors and their implications should only be made if they are strongly supported by the analysis. 7. Conclusion: The conclusion is not consistent with the findings. The results indicate that the variables analyzed are not significantly associated with TMD and do not suggest any interaction. Instead, the findings highlight that the crude analysis was likely confounded. The conclusion should be rewritten to reflect these points accurately. Reviewer #3: The introduction aligns well with the research objectives, emphasizing the biopsychosocial model and the complex interactions between genetic, emotional, and behavioral factors. The particularly relevant references to twin studies genetic mechanisms and the role of genetics and epi strengthen the justification for the study design. The discussion explores how cognitive, behavioral, and emotional dimensions interact with pain perception in TMD, reinforcing the biopsychosocial model. The findings, including the role of pain catastrophizing, emotional regulation, and mindfulness, provide actionable insights for developing targeted interventions. The study effectively bridges psychosocial theories with clinical practice, providing a multidimensional understanding of TMD. Its innovative design, focusing on monozygotic twins, offers unique insights into genetic and environmental contributions. Future work should aim to validate these findings in diverse and larger populations, using more sophisticated statistical models to unravel the intricate web of influencing factors. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #2: Yes: Ana Miriam Velly Reviewer #3: Yes: Stechman-Neto, J ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
<p>Phenotypes of painful TMD in discordant monozygotic twins according to a cognitive-behavioral-emotional model: a case-control study PONE-D-24-27113R2 Dear Dr. Leite-Panissi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cristiano Miranda de Araujo Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: Current and relevant topic. The manuscript is well-structured, and the English is comprehensible. The previous suggestions have been accepted, and no further changes are needed. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-24-27113R2 PLOS ONE Dear Dr. Leite-Panissi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Cristiano Miranda de Araujo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .